日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells.

PARP14 介导的糖酵解增强雌激素受体阳性乳腺癌细胞对他莫昔芬的耐药性

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02404-7
Mo Wenju, Zhang Fanrong, Wang Chen, Ding Xiaowen, Ren Lili
细胞生物学
乳腺癌
PARP1
发表日期：2025
文献求助 收藏

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients

新辅助蒽环类药物方案治疗HER2阳性乳腺癌的价值：一项纳入1366例患者的系统评价和荟萃分析

期刊:Clinical Medicine Insights-Oncology
影响因子:1.9
doi:10.1177/11795549231195293
Ding, Yuqin; Ding, Kaijing; He, Xiangming; Mo, Wenju; Liang, Chenlu; Gong, Lijie; Huang, Yuting; Ding, Xiaowen
肿瘤免疫
HER2
肿瘤
乳腺癌
发表日期：2023
文献求助 收藏

Study of lncRNA TPA in Promoting Invasion and Metastasis of Breast Cancer Mediated by TGF-β Signaling Pathway

lncRNA TPA通过TGF-β信号通路促进乳腺癌侵袭和转移的研究

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2021.688751
Li, Qinglin; Mo, Wenju; Ding, Yuqin; Ding, Xiaowen
肿瘤
肿瘤免疫
TGF-β
信号转导
乳腺癌
lncRNA
TPA
发表日期：2021
文献求助 收藏

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience

新辅助化疗期间乳腺癌进展性疾病的治疗选择：单中心经验

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2020.1756707
Zheng, Yurong; Ding, Xiaowen; Zou, Dehong; Zhang, Fanrong; Qin, Chengdong; Yang, Hongjian; Mo, Wenju; Ding, Yuqin; Yu, Yang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients

基于机器学习的磁共振图像放射组学列线图用于预测乳腺癌患者新辅助化疗疗效

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2020.01410
Chen, Shujun; Shu, Zhenyu; Li, Yongfeng; Chen, Bo; Tang, Lirong; Mo, Wenju; Shao, Guoliang; Shao, Feng
肿瘤免疫
肿瘤
乳腺癌
发表日期：2020
文献求助 收藏

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis

基于整合多组学数据分析，鉴定出用于预测乳腺癌患者生存期的6基因特征

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0241924
Mo, Wenju; Ding, Yuqin; Zhao, Shuai; Zou, Dehong; Ding, Xiaowen
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China

新辅助化疗后低激素受体阳性乳腺癌患者的预后及内分泌治疗选择：一项中国570例患者的回顾性研究

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2019.11033
Ding, Yuqin; Ding, Kaijing; Yu, Kun; Zou, Dehong; Yang, Hongjian; He, Xiangming; Mo, Wenju; Yu, Xingfei; Ding, Xiaowen
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2019
文献求助 收藏

Breast carcinoma associated with prolactinoma: A case report

乳腺癌合并泌乳素瘤：病例报告

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2017.1294284
Zheng, Yurong; Mo, Wenju; Yu, Yang; Zou, Dehong; He, Xiangming; Xia, Xianghou; Hu, Jiejie
肿瘤
肿瘤免疫
乳腺癌
发表日期：2017
文献求助 收藏

Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer

长链非编码RNA可作为乳腺癌合并原发性肺癌的生物标志物

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.17356
Ding, Xianfeng; Zhang, Yuhan; Yang, Hongjian; Mao, Weimin; Chen, Bo; Yang, Shifeng; Ding, Xiaowen; Zou, Dehong; Mo, Wenju; He, Xiangming; Zhang, Xiping
肺癌
肿瘤
肿瘤免疫
乳腺癌
发表日期：2017
文献求助 收藏